Cargando…

Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)

Detalles Bibliográficos
Autores principales: Varona, Jose F., García-Isidro, Millán, Moeinvaziri, Mojdeh, Ramos-López, María, Fernández-Domínguez, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271354/
https://www.ncbi.nlm.nih.gov/pubmed/34256983
http://dx.doi.org/10.1016/j.ejim.2021.06.025
_version_ 1783720982187343872
author Varona, Jose F.
García-Isidro, Millán
Moeinvaziri, Mojdeh
Ramos-López, María
Fernández-Domínguez, Manuel
author_facet Varona, Jose F.
García-Isidro, Millán
Moeinvaziri, Mojdeh
Ramos-López, María
Fernández-Domínguez, Manuel
author_sort Varona, Jose F.
collection PubMed
description
format Online
Article
Text
id pubmed-8271354
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher European Federation of Internal Medicine. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-82713542021-07-20 Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT) Varona, Jose F. García-Isidro, Millán Moeinvaziri, Mojdeh Ramos-López, María Fernández-Domínguez, Manuel Eur J Intern Med Letter to the Editor European Federation of Internal Medicine. Published by Elsevier B.V. 2021-09 2021-07-10 /pmc/articles/PMC8271354/ /pubmed/34256983 http://dx.doi.org/10.1016/j.ejim.2021.06.025 Text en © 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Varona, Jose F.
García-Isidro, Millán
Moeinvaziri, Mojdeh
Ramos-López, María
Fernández-Domínguez, Manuel
Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)
title Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)
title_full Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)
title_fullStr Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)
title_full_unstemmed Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)
title_short Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT)
title_sort primary adrenal insufficiency associated with oxford-astrazeneca chadox1 ncov-19 vaccine-induced immune thrombotic thrombocytopenia (vitt)
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8271354/
https://www.ncbi.nlm.nih.gov/pubmed/34256983
http://dx.doi.org/10.1016/j.ejim.2021.06.025
work_keys_str_mv AT varonajosef primaryadrenalinsufficiencyassociatedwithoxfordastrazenecachadox1ncov19vaccineinducedimmunethromboticthrombocytopeniavitt
AT garciaisidromillan primaryadrenalinsufficiencyassociatedwithoxfordastrazenecachadox1ncov19vaccineinducedimmunethromboticthrombocytopeniavitt
AT moeinvazirimojdeh primaryadrenalinsufficiencyassociatedwithoxfordastrazenecachadox1ncov19vaccineinducedimmunethromboticthrombocytopeniavitt
AT ramoslopezmaria primaryadrenalinsufficiencyassociatedwithoxfordastrazenecachadox1ncov19vaccineinducedimmunethromboticthrombocytopeniavitt
AT fernandezdominguezmanuel primaryadrenalinsufficiencyassociatedwithoxfordastrazenecachadox1ncov19vaccineinducedimmunethromboticthrombocytopeniavitt